Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance. [electronic resource] by
- Ji, Ning
- Yang, Yuqi
- Lei, Zi-Ning
- Cai, Chao-Yun
- Wang, Jing-Quan
- Gupta, Pranav
- Xian, Xiaomeng
- Yang, Dong-Hua
- Kong, Dexin
- Chen, Zhe-Sheng
Producer: 20190603
In:
Biochemical pharmacology vol. 158
Availability: No items available.
|
|
|
8.
|
Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells. [electronic resource] by
- Ji, Ning
- Yang, Yuqi
- Cai, Chao-Yun
- Lei, Zi-Ning
- Wang, Jing-Quan
- Gupta, Pranav
- Shukla, Suneet
- Ambudkar, Suresh V
- Kong, Dexin
- Chen, Zhe-Sheng
Producer: 20191011
In:
Cancer letters vol. 440-441
Availability: No items available.
|
|
|
9.
|
VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters. [electronic resource] by
- Ji, Ning
- Yang, Yuqi
- Cai, Chao-Yun
- Lei, Zi-Ning
- Wang, Jing-Quan
- Gupta, Pranav
- Teng, Qiu-Xu
- Chen, Zhe-Sheng
- Kong, Dexin
- Yang, Dong-Hua
Publication details: Frontiers in pharmacology 2018
In:
Frontiers in pharmacology vol. 9
Availability: No items available.
|
|
|
10.
|
Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an [electronic resource] by
- Ji, Ning
- Yang, Yuqi
- Cai, Chao-Yun
- Wang, Jing-Quan
- Lei, Zi-Ning
- Wu, Zhuo-Xun
- Cui, Qingbin
- Yang, Dong-Hua
- Chen, Zhe-Sheng
- Kong, Dexin
Publication details: Frontiers in oncology 2019
In:
Frontiers in oncology vol. 9
Availability: No items available.
|
|
|
11.
|
Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells. [electronic resource] by
- Wang, Jing-Quan
- Li, Jonathan Y
- Teng, Qiu-Xu
- Lei, Zi-Ning
- Ji, Ning
- Cui, Qingbin
- Zeng, Leli
- Pan, Yihang
- Yang, Dong-Hua
- Chen, Zhe-Sheng
Publication details: Cancers Feb 2020
In:
Cancers vol. 12
Availability: No items available.
|
|
|
12.
|
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells. [electronic resource] by
- Wang, Jingqiu
- Yang, Dong-Hua
- Yang, Yuqi
- Wang, Jing-Quan
- Cai, Chao-Yun
- Lei, Zi-Ning
- Teng, Qiu-Xu
- Wu, Zhuo-Xun
- Zhao, Linguo
- Chen, Zhe-Sheng
Producer: 20210104
In:
International journal of molecular sciences vol. 21
Availability: No items available.
|
|
|
13.
|
Establishment and characterization of arsenic trioxide resistant KB/ATO cells. [electronic resource] by
- Zhang, Yun-Kai
- Dai, Chunling
- Yuan, Chun-Gang
- Wu, Hsiang-Chun
- Xiao, Zhijie
- Lei, Zi-Ning
- Yang, Dong-Hua
- Le, X Chris
- Fu, Liwu
- Chen, Zhe-Sheng
Publication details: Acta pharmaceutica Sinica. B Sep 2017
In:
Acta pharmaceutica Sinica. B vol. 7
Availability: No items available.
|
|
|
14.
|
Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression. [electronic resource] by
- Liao, Dan
- Zhang, Wei
- Gupta, Pranav
- Lei, Zi-Ning
- Wang, Jing-Quan
- Cai, Chao-Yun
- Vera, Albert A De
- Zhang, Lei
- Chen, Zhe-Sheng
- Yang, Dong-Hua
Producer: 20200423
In:
Molecules (Basel, Switzerland) vol. 24
Availability: No items available.
|
|
|
15.
|
Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor. [electronic resource] by
- Cai, Chao-Yun
- Zhang, Wei
- Wang, Jing-Quan
- Lei, Zi-Ning
- Zhang, Yun-Kai
- Wang, Yi-Jun
- Gupta, Pranav
- Tan, Cai-Ping
- Wang, Bo
- Chen, Zhe-Sheng
Producer: 20201029
In:
Biochemical pharmacology vol. 175
Availability: No items available.
|
|
|
16.
|
Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells. [electronic resource] by
- Wu, Zhuo-Xun
- Teng, Qiu-Xu
- Cai, Chao-Yun
- Wang, Jing-Quan
- Lei, Zi-Ning
- Yang, Yuqi
- Fan, Ying-Fang
- Zhang, Jian-Ye
- Li, Jun
- Chen, Zhe-Sheng
Producer: 20200330
In:
Biochemical pharmacology vol. 166
Availability: No items available.
|
|
|
17.
|
Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance. [electronic resource] by
- Wu, Zhuo-Xun
- Yang, Yuqi
- Teng, Qiu-Xu
- Wang, Jing-Quan
- Lei, Zi-Ning
- Wang, Jing-Qiu
- Lusvarghi, Sabrina
- Ambudkar, Suresh V
- Yang, Dong-Hua
- Chen, Zhe-Sheng
Publication details: Cancers Jan 2020
In:
Cancers vol. 12
Availability: No items available.
|
|
|
18.
|
Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters. [electronic resource] by
- Fan, Ying-Fang
- Zhang, Wei
- Zeng, Leli
- Lei, Zi-Ning
- Cai, Chao-Yun
- Gupta, Pranav
- Yang, Dong-Hua
- Cui, Qingbin
- Qin, Zuo-Dong
- Chen, Zhe-Sheng
- Trombetta, Louis D
Producer: 20190506
In:
Cancer letters vol. 421
Availability: No items available.
|
|
|
19.
|
Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance. [electronic resource] by
- Wang, Jing-Quan
- Wang, Bo
- Lei, Zi-Ning
- Teng, Qiu-Xu
- Li, Jonathan Y
- Zhang, Wei
- Ji, Ning
- Cai, Chao-Yun
- Ma, Li-Ying
- Liu, Hong-Min
- Chen, Zhe-Sheng
Producer: 20200323
In:
European journal of pharmacology vol. 863
Availability: No items available.
|
|
|
20.
|
Benzoyl indoles with metabolic stability as reversal agents for ABCG2-mediated multidrug resistance. [electronic resource] by
- Cai, Chao-Yun
- Zhai, Hong
- Lei, Zi-Ning
- Tan, Cai-Ping
- Chen, Bao-Li
- Du, Zhao-Yi
- Wang, Jing-Quan
- Zhang, Yun-Kai
- Wang, Yi-Jun
- Gupta, Pranav
- Wang, Bo
- Chen, Zhe-Sheng
Producer: 20191104
In:
European journal of medicinal chemistry vol. 179
Availability: No items available.
|